FDA Investigator: Sean R. Byrd

- Sean R. Byrd first started conducting FDA inspections in 2006, with the last inspection in 2014. Over that time, Sean R. Byrd has conducted 13 inspections at 13 companies across 13 sites.

Documents

FDA 483 CSL Behring L.L.C., Bradley | 2014

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Cook Pharmica, LLC, Bloomington | 2012

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Kedrion S.p.A., Bolognana | 2011

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Grifols Biologicals Inc., Clayton | 2010

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals Kft., Godollo | 2010

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2009

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Sanofi Pasteur SA, Lyon | 2009

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Sanofi Pasteur Limited - Cannaught Campus, North York | 2008

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Novartis Vaccines And Diagnostics Srl, Sovicille | 2008

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 Lonza Walkersville, Inc., Walkersville | 2007

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 ID Biomedical Corp., a subsidary of GSK Biologicals, St. Foy | 2007

Out-of-stock
Sean R. Byrd
Biologic Form 483

FDA 483 AbbVie Research Bioresearch Center, Worcester | 2007

Out-of-stock
Sean R. Byrd
Human Drug Form 483

FDA 483 Baxter Pharmaceutical Solutions, LLC, Bloomington | 2006

Out-of-stock
Sean R. Byrd
Biologic Form 483